Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1[ALN-62643]----[1] 109 💬
2[RO7112689/F03-01]----[1] 109 💬
3[RO7112689/F03-10]----[1] 109 💬
4ALN-CC5----[4] 11, 62, 66, 109 💬
5ALXN1210----[7] 2, 11, 13, 50, 62, 66, 109 💬
6Anti-C5 antibody----[4] 11, 14, 62, 109 💬
7C5 inh MAb, SKY59, RO/CH7092230----[2] 62, 109 💬
8CCX168----[6] 43, 44, 49, 66, 109, 223 💬
9Cemdisiran[1] Cemdisiran---[6] 11, 15, 62, 66, 109, 223 💬
10COVERSIN----[2] 62, 109 💬
11Crovalimab[1] Crovalimab[1] Crovalimab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[3] 48, 62, 109 💬
12CrovalimabProduct Code: RO7112689/F03-10Pharmaceutical Form: Solution for injection/infusionINN or Proposed INN: CROVALIMABCurrent Sponsor code: RO7112689Other descriptive name: C5 inh MAb, SKY59, RO/CH7092230Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 170-Product Name: CrovalimabProduct Code: RO7112689/F03-01Pharmaceutical Form: Solution for injection/infusionINN or Proposed INN: CROVALIMABCurrent Sponsor code: RO7112689Other descriptive name: C5 inh MAb, SKY59, RO/CH7092230Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 170-----[1] 109 💬
13ECULIZUMAB[1] Eculizumab[1] Eculizumab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[8] 11, 13, 14, 61, 62, 109, 221, 223 💬
14Fc- and CDR-modified humanised monoclonal antibody against C5----[3] 11, 62, 109 💬
15IgG2/4?----[1] 109 💬
16Iptacopan[1] Iptacopan[2] Iptacopan ,
Iptacopan hydrochloride 💬 		[1] CFB 💬 [3] Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬[8] 11, 61, 62, 63, 66, 109, 222, 223 💬
17Iptacopan hydrochloride[1] Iptacopan[2] Iptacopan ,
Iptacopan hydrochloride 💬 		[1] CFB 💬 [3] Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬[5] 61, 63, 66, 109, 223 💬
18Iptcaopan 200 mg----[1] 109 💬
19LNP023----[7] 61, 62, 63, 66, 109, 222, 223 💬
20NM8074----[5] 50, 62, 66, 109, 223 💬
21OMS00620646, OMS620646, MASP-2 Antibody----[1] 109 💬
22OMS721----[3] 64, 66, 109 💬
23OMS721 100 mg/ml Injection solution, OMS00620646, OMS620646, MASP-2 Antibody----[2] 64, 109 💬
24OMS721 185 mg/ml Injection solution, OMS00620646, OMS620646, MASP-2 Antibody----[2] 64, 109 💬
25OMS721 Drug Product 185 mg/mL----[1] 109 💬
26Other: Blood sampling and urine analysis----[1] 109 💬
27Other: Eculizumab[1] Eculizumab[1] Eculizumab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 109 💬
28RAVULIZUMAB[1] Ravulizumab[1] Ravulizumab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[8] 2, 11, 13, 50, 62, 66, 109, 224 💬
29RO7112689/F03-01----[2] 62, 109 💬
30RO7112689/F03-10----[2] 62, 109 💬
31RVA576----[3] 62, 109, 162 💬
32RVA576 (COVERSIN)----[2] 62, 109 💬
33Solaris----[2] 62, 109 💬
34SOLIRIS----[6] 11, 13, 14, 62, 109, 223 💬
35SOLIRIS - 300 MG CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO 1 FLACONCINO (VETRO) 30 ML (10 MG/ML)----[3] 13, 62, 109 💬
36SOLIRIS 300 mg concentrado para solución para perfusión----[1] 109 💬
37Soliris 300 mg solution à diluer pour perfusion----[1] 109 💬
38Ultomiris----[7] 2, 11, 13, 50, 62, 66, 109 💬
39 LNP023 HYDROCHLORIDE SALT----[7] 61, 62, 63, 66, 109, 222, 223 💬